PMID- 26983613 OWN - NLM STAT- MEDLINE DCOM- 20161228 LR - 20181113 IS - 1995-8218 (Electronic) IS - 1673-7067 (Print) IS - 1995-8218 (Linking) VI - 32 IP - 2 DP - 2016 Apr TI - S-adenosylmethionine Administration Attenuates Low Brain-Derived Neurotrophic Factor Expression Induced by Chronic Cerebrovascular Hypoperfusion or Beta Amyloid Treatment. PG - 153-61 LID - 10.1007/s12264-016-0023-z [doi] AB - Chronic cerebrovascular hypoperfusion is a high-risk factor for Alzheimer's disease (AD) as it is conducive to beta amyloid (Abeta) over-production. Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family widely expressed in the central nervous system. The structure of the rat BDNF gene is complex, consisting of eight non-coding exons (I-VIII) and one coding exon (IX). The BDNF gene is transcribed from multiple promoters located upstream of different 5' non-coding exons to produce a heterogeneous population of BDNF mRNAs. S-adenosylmethionine (SAM) produced in the methionine cycle is the primary methyl donor and the precursor of glutathione. In this study, a cerebrovascular hypoperfusion rat model and an Abeta intrahippocampal injection rat model were used to explore the expression profiles of all BDNF transcripts in the hippocampus with chronic cerebrovascular hypoperfusion or Abeta injection as well as with SAM treatment. We found that the BDNF mRNAs and protein were down-regulated in the hippocampus undergoing chronic cerebrovascular hypoperfusion as well as Abeta treatment, and BDNF exons IV and VI played key roles. SAM improved the low BDNF expression following these insults mainly through exons IV and VI. These results suggest that SAM plays a neuroprotective role by increasing the expression of endogenous BDNF and could be a potential target for AD therapy. FAU - Li, Qian AU - Li Q AD - Department of Pathology, Capital Medical University, Beijing, 100069, China. FAU - Cui, Jing AU - Cui J AD - Department of Pathology, Capital Medical University, Beijing, 100069, China. FAU - Fang, Chen AU - Fang C AD - Department of Pathology, Capital Medical University, Beijing, 100069, China. FAU - Zhang, Xiaowen AU - Zhang X AD - Department of Pathology, Capital Medical University, Beijing, 100069, China. FAU - Li, Liang AU - Li L AD - Department of Pathology, Capital Medical University, Beijing, 100069, China. liliang8698@yeah.net. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20160316 PL - Singapore TA - Neurosci Bull JT - Neuroscience bulletin JID - 101256850 RN - 0 (Amyloid beta-Peptides) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Neuroprotective Agents) RN - 0 (Peptide Fragments) RN - 0 (RNA, Messenger) RN - 0 (amyloid beta-protein (1-42)) RN - 7LP2MPO46S (S-Adenosylmethionine) SB - IM MH - Amyloid beta-Peptides/*toxicity MH - Analysis of Variance MH - Animals MH - Brain-Derived Neurotrophic Factor/genetics/*metabolism MH - *Carotid Stenosis/drug therapy/metabolism/pathology MH - Disease Models, Animal MH - Exons/drug effects/physiology MH - Gene Expression Regulation/*drug effects MH - Hippocampus/drug effects/metabolism MH - Male MH - Neuroprotective Agents/*therapeutic use MH - Peptide Fragments/*toxicity MH - RNA, Messenger MH - Rats MH - Rats, Sprague-Dawley MH - S-Adenosylmethionine/*therapeutic use MH - Time Factors PMC - PMC5563744 OTO - NOTNLM OT - Beta amyloid OT - Brain-derived neurotrophic factor OT - Cerebrovascular hypoperfusion OT - S-adenosylmethionine EDAT- 2016/03/18 06:00 MHDA- 2016/12/29 06:00 PMCR- 2017/04/01 CRDT- 2016/03/18 06:00 PHST- 2015/09/28 00:00 [received] PHST- 2015/12/14 00:00 [accepted] PHST- 2016/03/18 06:00 [entrez] PHST- 2016/03/18 06:00 [pubmed] PHST- 2016/12/29 06:00 [medline] PHST- 2017/04/01 00:00 [pmc-release] AID - 10.1007/s12264-016-0023-z [pii] AID - 23 [pii] AID - 10.1007/s12264-016-0023-z [doi] PST - ppublish SO - Neurosci Bull. 2016 Apr;32(2):153-61. doi: 10.1007/s12264-016-0023-z. Epub 2016 Mar 16.